ElliottWave Forecast
July 03, 2023
ElliottWave-Forecast has built its reputation on accurate technical analysis and a winning attitude. By successfully incorporating the Elliott Wave Theory with Market Correlation, Cycles, Proprietary Pivot System, we provide precise forecasts with up-to-date analysis for 50 instruments including FX majors, Gold, Silver, Copper, Oil, Natural Gas, Soybeans, Sugar ,Corn TNX and a number of Equity Indices from around the World. Our clients also have immediate access to our proprietary Actionable Trade Setups, Market Overview, 1 Hour, 4 Hour, Daily & Weekly Wave Counts. Weekend Webinar, Live Screen Sharing Sessions, Daily Technical Videos, Elliott Wave Setup videos, Educational Resources, and 24 Hour chat room where they are provided live updates and given answers to their questions. The guidance of ElliottWave-Forecast gives subscribers the wherewithal to position themselves for proper entry and exit in the Forex marketplace. We believe our disciplined methodology is pivotal for long-term success in trading.

AbbVie Inc. ($ABBV) Is Poised To Rally Soon From a Blue Box Area.

Hello Traders! Today, we will look at the Daily Elliott Wave structure of AbbVie Inc. ($ABBV) and explain why the stock should soon reach a Blue Box area and react higher.

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. The company's primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohn's disease, plaque psoriasis, and ulcerative colitis.

$ABBV Daily Elliott Wave View July 3rd 2023:

$ABBV

The Daily chart above shows the cycle from April 2022 peak unfold in a double three (WXY) corrective structure. The stock should be at the tail end of the correction towards the Blue Box area at $126.39 - 100.60 where buyers are expected to appear and start the next cycle higher. Although, we like it lower right now towards the blue box, traders should not be short selling the last swing lower as truncations can happen at this stage of the market.

We have a bullish sequence against March 2020 lows. As long as price remains above the invalidation level at $100.60, $ABBV is expected to rally soon. Remember, corrections run in  3, 7 or 11 swings,  so risk management should be exercised. The market could bounce and end up doing 11 swings lower before higher so we like to book partial profits and get risk free once the bounce takes place from the blue box.

Source:  https://elliottwave-forecast.com/video-blog/abbvie-inc-abbv-poised-rally-soon-blue-box-area/ 

More from ElliottWave Forecast